These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15154878)

  • 41. Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy.
    Tamura K; Suzuki Y; Hashiba H; Tamura H; Aizawa S; Kogo H
    J Pharmacol Sci; 2005 Sep; 99(1):89-94. PubMed ID: 16141638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of ectopic calcification in uremia.
    Zucchelli P; Fusaroli M; Fabbri L; Pavlica P; Casanova S; Viglietta G; Sasdelli M
    Kidney Int Suppl; 1978 Jun; (8):S86-90. PubMed ID: 99599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Beneficial effect of high-dose etidronate on periarticular calcinosis associated with arterial and periarticular basic calcium phosphate (BCP) crystal deposition disease].
    Ito G; Suzuki Y; Uehara R; Ide M; Ozaki S
    Ryumachi; 2003 Oct; 43(4):644-8. PubMed ID: 14598656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
    Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
    Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etidronate for the treatment of progressive tumoral calcinosis in hemodialysis patients.
    Mori H; Okada Y; Tanaka Y
    Intern Med; 2007; 46(17):1485-6. PubMed ID: 17827857
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.
    Grases F; Sanchis P; Perelló J; Isern B; Prieto RM; Fernández-Palomeque C; Torres JJ
    Circ J; 2007 Jul; 71(7):1152-6. PubMed ID: 17587727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of plasma exchange for liver failure: beneficial and harmful effects.
    Abe T; Kobata H; Hanba Y; Kitabata Y; Narukawa N; Hasegawa H; Abe T; Fukagawa M
    Ther Apher Dial; 2004 Jun; 8(3):180-4. PubMed ID: 15154867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of etidronate on calcification of scales and ribs in the goldfish, Carassius auratus.
    Iguchi M
    Fish Physiol Biochem; 2012 Apr; 38(2):483-91. PubMed ID: 21695481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic calcification in the course of hemodialysis.
    Sugiura H; Yoshida K; Nakanuma Y; Ohta G; Izumino K; Takazakura H
    Am J Gastroenterol; 1987 Aug; 82(8):786-9. PubMed ID: 3605041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.
    Mori H; Okada Y; Yamaoka K; Saito K; Tanaka Y
    J Bone Miner Metab; 2012 Jan; 30(1):114-8. PubMed ID: 21710176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
    Obad D; Larsen NA; Pedersen EB
    Ugeskr Laeger; 2010 Mar; 172(9):719-21. PubMed ID: 20199755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
    Ferrante EA; Cudrici CD; Rashidi M; Fu YP; Huffstutler R; Carney K; Chen MY; St Hilaire C; Smith K; Bagheri H; Katz JD; Ferreira CR; Gahl WA; Boehm M; Brofferio A
    Vasc Med; 2024 Jun; 29(3):245-255. PubMed ID: 38568107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with calcification of the abdominal aorta in hemodialysis patients.
    Kimura K; Saika Y; Otani H; Fujii R; Mune M; Yukawa S
    Kidney Int Suppl; 1999 Jul; 71():S238-41. PubMed ID: 10412787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans].
    Gennari C; Orlandini GA; Nuti R; Francini G
    Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911
    [No Abstract]   [Full Text] [Related]  

  • 55. Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention.
    Rufino M; García S; Jiménez A; Alvarez A; Miquel R; Delgado P; Marrero D; Torres A; Hernández D; Lorenzo V
    Kidney Int Suppl; 2003 Jun; (85):S115-8. PubMed ID: 12753280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron overloading inhibits dentine mineralization.
    De Lucca RC; Mandalunis PM; Ubios AM
    Acta Odontol Latinoam; 1999; 12(2):75-81. PubMed ID: 12905907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation.
    Bauer C; le Saux O; Pomozi V; Aherrahrou R; Kriesen R; Stölting S; Liebers A; Kessler T; Schunkert H; Erdmann J; Aherrahrou Z
    Sci Rep; 2018 Apr; 8(1):5812. PubMed ID: 29643466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Inhibitory action of diphosphonate on the development of pancreatic concrements (experiment with EHDP (author's transl)].
    Klemm G; Putzke HP
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(3):128-34. PubMed ID: 6790262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disodium etidronate therapy for dystrophic cutaneous calcification.
    Rabens SF; Bethune JE
    Arch Dermatol; 1975 Mar; 111(3):357-61. PubMed ID: 804294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.